CD59 and familial pancreatic carcinoma: In this study, we showed that the expression levels of CD59 in clinical specimens were positively correlated with a worse prognosis for pancreatic cancer patients and that CD59 expression was positively correlated with TAM infiltration in pancreatic cancer tissues.